Tobacco smoking cessation in adults and pregnant women: Behavioral and pharmacotherapy interventions
Cet article présente les recommandations de l' "US Preventive Services Task Force" en matière d'interventions comportementales et pharmacothérapeutiques pour aider les femmes enceintes et les adultes à arrêter de fumer
Guideline title : Tobacco Smoking Cessation in Adults and Pregnant Women : Behavioral and Pharmacotherapy Interventions Developer US Preventive Services Task Force (USPSTF) Release date October 20, 2015 Prior versions April 21, 2009; November 13, 2003 Funding source US Agency for Healthcare Research and Quality (AHRQ) Target population All adults aged 18 years or older, including pregnant women Major recommendations Ask all adults about tobacco use; if using, advise patients to quit. Provide behavioral interventions to all adults who use tobacco regardless of pregnancy status. Prescribe Food and Drug Administration (FDA)–approved cessation pharmacotherapy to all nonpregnant adults who use tobacco (grade A recommendations). There is insufficient evidence to recommend pharmacologic interventions for tobacco cessation in pregnant adults (I statement). There is also insufficient evidence to recommend use of electronic nicotine delivery systems for tobacco cessation in any adults (I statement).